| A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reynies, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 1154 | 2020 |
| Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018 MGK Cumberbatch, I Jubber, PC Black, F Esperto, JD Figueroa, ... European urology 74 (6), 784-795, 2018 | 876 | 2018 |
| Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ... European urology 72 (4), 544-554, 2017 | 839 | 2017 |
| Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi, C Buerki, ... PloS one 8 (6), e66855, 2013 | 706 | 2013 |
| Enhanced recovery after surgery (ERAS) protocols: Time to change practice? M Melnyk, RG Casey, P Black, AJ Koupparis Canadian Urological Association Journal 5 (5), 342, 2011 | 643 | 2011 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study D Lobo, JM Devys Anaesthesia 77 (1), 110, 2021 | 584* | 2021 |
| Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population RJ Karnes, EJ Bergstralh, E Davicioni, M Ghadessi, C Buerki, AP Mitra, ... The Journal of urology 190 (6), 2047-2053, 2013 | 371 | 2013 |
| Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance C Kollmannsberger, T Tandstad, PL Bedard, G Cohn-Cedermark, ... Journal of Clinical Oncology 33 (1), 51-57, 2015 | 367 | 2015 |
| Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer H Zargar, PN Espiritu, AS Fairey, LS Mertens, CP Dinney, MC Mir, ... European urology 67 (2), 241-249, 2015 | 323 | 2015 |
| Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature LA Kluth, PC Black, BH Bochner, J Catto, SP Lerner, A Stenzl, R Sylvester, ... European urology 68 (2), 238-253, 2015 | 305 | 2015 |
| The impact of variant histology on the outcome of bladder cancer treated with curative intent PC Black, GA Brown, CPN Dinney Urologic Oncology: Seminars and Original Investigations 27 (1), 3-7, 2009 | 289 | 2009 |
| Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ... JAMA oncology 3 (12), 1663-1672, 2017 | 287 | 2017 |
| Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments C Jin, SM McFaul, SP Duffy, X Deng, P Tavassoli, PC Black, H Ma Lab on a Chip 14 (1), 32-44, 2014 | 245 | 2014 |
| Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder JL Wright, PC Black, GA Brown, MP Porter, AM Kamat, CP Dinney, ... The Journal of urology 178 (6), 2302-2307, 2007 | 230 | 2007 |
| Epidemiology of bladder cancer in 2023: a systematic review of risk factors I Jubber, S Ong, L Bukavina, PC Black, E Compérat, AM Kamat, ... European urology 84 (2), 176-190, 2023 | 221 | 2023 |
| Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita JYC Teoh, J Huang, WYK Ko, V Lok, P Choi, CF Ng, S Sengupta, ... European urology 78 (6), 893-906, 2020 | 213 | 2020 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 203 | 2020 |
| Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells S Park, RR Ang, SP Duffy, J Bazov, KN Chi, PC Black, H Ma PloS one 9 (1), e85264, 2014 | 203 | 2014 |
| Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer G Vandekerkhove, WJ Struss, M Annala, HML Kallio, D Khalaf, ... European urology 75 (4), 667-675, 2019 | 193 | 2019 |
| Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts G Nir, S Hor, D Karimi, L Fazli, BF Skinnider, P Tavassoli, D Turbin, ... Medical image analysis 50, 167-180, 2018 | 184 | 2018 |